secwatch.observer — SEC 8-K summary
======================================

Issuer:     Krystal Biotech, Inc. (KRYS)
CIK:        0001711279
Form:       8-K
Filed at:   2022-01-18T23:59:59+00:00
Accession:  0001193125-22-011224
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Krystal Biotech appoints Jing Marantz as CBO, adds Rand Sutherland to board
---------------------------------------------------------------------------

- Jing Marantz resigns from board effective Jan 18, 2022, to become Chief Business Officer.
- E. Rand Sutherland appointed to board same day; no committee assignments initially.
- Marantz previously SVP at Acceleron, Alnylam, Alexion; Sutherland was president of Translate Bio.
- Marantz's resignation not due to any disagreement with Krystal.
- Both appointments effective January 18, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711279/000119312522011224/0001193125-22-011224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711279/000119312522011224/d294817d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-011224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer